This report provides an analysis of possible ways to enter the market, together with detailed descriptions of how existing players have entered the market, including key contracts, alliances, and strategic initiatives.
SDIs ""The Chinese Defense Industry - Market Entry Strategy to 2020: Market Profile"" is an essential source of information covering the market entry strategy into the defense industry in China.
It discusses key market entry aspects such as: market regulation, entry route and key challenges to entering the market, to offer the reader a better understanding of how the China defense industry operates and what business opportunities are available to them as new market entrants.
Reasons To Buy
""The Chinese Defense Industry - Market Entry Strategy to 2020: Market Profile"" allows you to:
- Understand the market regulations in the China defense industry.
- Get insight on market entry route into the market.
- Understand the key challenges to enter into the market.
1.1 What is this Report About?
1.3 Summary Methodology
1.4 SDI Terrorism Index
1.5 About Strategic Defence Intelligence
2 Market Entry Strategy
2.1 Market Regulation
2.1.1 The Chinese military-industrial complex opens up to private sector participation
2.1.2 Defense industry remains closed to foreign direct investment
2.2 Market Entry Route
2.2.1 Foreign technology finds its way into the Chinese defense industry through civil-military integration
2.3 Key Challenges
2.3.1 Lack of competition and long production cycles continue to hamper the performance of the Chinese defense industry
2.3.2 Arms embargo imposed by the US and EU
3.1 About SDI
Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The companys pipeline products include
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases.
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which
VR (Virtual Reality) has been deemed to become the next big computing platform, on par with computers and smartphones. Following the launch of consumer-friendly HMDs (Head-mounted devices) such as Oculus
USD 1600View Report
This report presents a recent review of the Chinese smartphone industry in the second quarter of 2016, including shipment volume of major smartphone brands in China, breakdowns of each vendors
USD 2800View Report
This report presents a recent review of the Chinese smartphone industry in the fourth quarter of 2015. The report includes shipment volume of major smartphone brands in China, breakdowns of
USD 2800View Report
PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)
|Published Date||:||Jul 2015|
|No. of Pages||:||10|
|Publisher||:||Strategic Defence Intelligence|
|Report Delivery By||:|
|Report Delivery Time||:||12 to 24 hours after placing the order.|
If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE